{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:54:05Z","timestamp":1790776445813,"version":"4.1.0"},"reference-count":118,"publisher":"Korean Association for the Study of Intestinal Diseases","issue":"1","license":[{"start":{"date-parts":[[2022,10,18]],"date-time":"2022-10-18T00:00:00Z","timestamp":1666051200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["irjournal.org"],"crossmark-restriction":true},"short-container-title":["Intest Res"],"published-print":{"date-parts":[[2023,1,31]]},"abstract":"<jats:p>Crohn\u2019s disease (CD) is a relapsing and progressive condition characterized by diarrhea, abdominal pain, weight loss, and hematochezia that results in serious complications such as perforations, fistulas, and abscesses. Various medications, interventions, and surgical treatments have been used to treat CD. The Korean guidelines for CD management were distributed in 2012 and revised in 2017 by the Inflammatory Bowel Disease (IBD) Research Group of the Korean Association for the Study of Intestinal Diseases. Substantial progress in mucosal immunologic research has elucidated the pathophysiology of IBD, leading to development of biological agents for treatment of CD. The first developed biologic agent, tumor necrosis factor-\u03b1 agents, were shown to be efficacious in CD, heralding a new era in management of CD. Subsequently, vedolizumab, a monoclonal antibody against integrin \u03b14\u03b27, and ustekinumab, a human monoclonal antibody that inhibits the common p40 subunit of interleukin-12 and interleukin-23, were both approved for clinical use and are efficacious and safe for both induction and maintenance of remission in moderate-to-severe CD patients. Moreover, a recent study showed the non-inferiority of CT-P13, an infliximab biosimilar, compared with infliximab in CD patients. The third Korean guidelines for CD management provide updated information regarding treatment of moderate-to-severe CD patients with biologic agents.<\/jats:p>","DOI":"10.5217\/ir.2022.00029","type":"journal-article","created":{"date-parts":[[2022,10,17]],"date-time":"2022-10-17T04:53:10Z","timestamp":1665982390000},"page":"43-60","update-policy":"https:\/\/doi.org\/10.5217\/crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Korean clinical practice guidelines on biologics for moderate to severe Crohn\u2019s disease"],"prefix":"10.5217","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8001-8777","authenticated-orcid":true,"given":"Seong-Joon","family":"Koh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4140-3717","authenticated-orcid":true,"given":"Sung Noh","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3125-7688","authenticated-orcid":true,"given":"Soo-Kyung","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6647-6325","authenticated-orcid":true,"given":"Byong Duk","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5799-7436","authenticated-orcid":true,"given":"Kyeong Ok","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5706-3967","authenticated-orcid":true,"given":"Jeong Eun","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3196-8423","authenticated-orcid":true,"given":"Yong Sik","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2962-0209","authenticated-orcid":true,"given":"Hong Sub","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9075-2027","authenticated-orcid":true,"given":"Sung Hoon","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2424-9965","authenticated-orcid":true,"given":"Miyoung","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3685-6823","authenticated-orcid":true,"given":"Soo-Young","family":"Na","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7089-532X","authenticated-orcid":true,"given":"Chang Hwan","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6835-4735","authenticated-orcid":true,"given":"Joo Sung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the IBD Research Group of the Korean Association for the Study of Intestinal Diseases","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3168","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.5217\/ir.2021.00104"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1056\/nejmra2002697"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.5217\/ir.2019.09148"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2013.07.041"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjz081"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.14027"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2015.186"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1056\/nejm199710093371502"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1999.00025.x"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2011.04612.x"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1080\/00365521.2018.1447597"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.5217\/ir.2019.09154"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.4166\/kjg.2012.59.2.141"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.4166\/kjg.2017.69.1.29"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.5217\/ir.2019.09147"},{"key":"ref16","first-page":"2496","volume-title":"AGA clinical practice guidelines on the medical management of moderate to severe luminal and perianal fistulizing Crohn\u2019s disease","author":"Feuerstein","year":"2021"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2019-318484"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjz180"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2018.27"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1093\/jcag\/gwz019"},{"key":"ref21","volume-title":"Handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach [Internet]","author":"Sch\u00fcnemann","year":"2021"},{"key":"ref22","first-page":"1324","volume-title":"Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): determining therapeutic goals for treat-to-target","author":"Peyrin-Biroulet","year":"2015"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2020.12.031"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2009.220"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1215739"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1215734"},{"key":"ref27","first-page":"1946","volume-title":"Ustekinumab as induction and maintenance therapy for Crohn\u2019s disease","author":"Feagan","year":"2016"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1111\/apt.14852"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1097\/00054725-200002000-00002"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1155\/2005\/269076"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/s0016-5085(76)80163-1"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/s0016-5085(99)70332-x"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(02)08512-4"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2010.01.001"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(80)92767-1"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2009.12.002"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2006.02.014"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.11.030"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-146-12-200706190-00159"},{"key":"ref40","first-page":"1370","volume-title":"Treatment of active Crohn\u2019s disease with MLN0002, a humanized antibody to the alpha4beta7 integrin","author":"Feagan","year":"2008"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2014.05.008"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1203572"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izy333"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2006.106781"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2006.11.041"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2011.07.013"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa0904492"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjw152"},{"key":"ref49","first-page":"341","volume-title":"Predictors of antiTNF treatment failure in anti-TNF-naive patients with active luminal Crohn\u2019s disease: a prospective, multicentre, cohort study","author":"Kennedy","year":"2019"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2013.11.024"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1111\/apt.13083"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjy050"},{"key":"ref53","first-page":"606","volume-title":"Effectiveness and safety of the sequential use of a second and third antiTNF agent in patients with inflammatory bowel disease: results from the Eneida Registry","author":"Casanova","year":"2020"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izz286"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2016.01.009"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2020.03.064"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2008.03774.x"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2016.10.038"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1007\/s00384-008-0542-9"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(90)90613-6"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1159\/000089960"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2008.10.051"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.21928"},{"key":"ref64","first-page":"1568","volume-title":"Infliximab reduces endoscopic, but not clinical, recurrence of Crohn\u2019s disease after ileocolonic resection","author":"Regueiro","year":"2016"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2013.287"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2014.09.031"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjy216"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2013-305279"},{"key":"ref69","first-page":"2568","volume-title":"Therapeutic drug monitoring of infliximab and mucosal healing in inflammatory bowel disease: a prospective study","author":"Paul","year":"2013"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2013.07.010"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2014.07.029"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1056\/nejm199905063401804"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa030815"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2008.159251"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjy019"},{"key":"ref76","volume-title":"Guidelines on evaluation of similar biotherapeutic products (SBPs)","year":"2009"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1586\/1744666x.2015.1090311"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-203090"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-016-0981-6"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-203091"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-016-0930-4"},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.7326\/m18-1512"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(18)32196-2"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2021.02.068"},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-207764"},{"key":"ref86","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kex254"},{"key":"ref87","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-212245"},{"key":"ref88","doi-asserted-by":"publisher","DOI":"10.1080\/14712598.2021.1851362"},{"key":"ref89","doi-asserted-by":"publisher","DOI":"10.1016\/s2468-1253(21)00252-1"},{"key":"ref90","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-020-02394-7"},{"key":"ref91","first-page":"40","volume-title":"Phase III randomized study of SB5, an adalimumab biosimilar, versus reference adalimumab in patients with moderate-to-severe rheumatoid arthritis","author":"Weinblatt","year":"2018"},{"key":"ref92","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-06-583617"},{"key":"ref93","first-page":"2304","volume-title":"Switching from originator infliximab to biosimilar CT-P13 compared with maintained treatment with originator infliximab (NOR-SWITCH): a 52-week, randomised, double-blind, non-inferiority trial","author":"J\u00f8rgensen","year":"2017"},{"key":"ref94","doi-asserted-by":"publisher","DOI":"10.1007\/s40259-020-00438-7"},{"key":"ref95","first-page":"653","volume-title":"Long-term efficacy and safety of biosimilar infliximab (CT-P13) after switching from originator infliximab: open-label extension of the NOR-SWITCH trial","author":"Goll","year":"2019"},{"key":"ref96","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-211741"},{"key":"ref97","doi-asserted-by":"publisher","DOI":"10.1002\/art.40444"},{"key":"ref98","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-019-01647-w"},{"key":"ref99","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-018-1480-0"},{"key":"ref100","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/6317057"},{"key":"ref101","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2021.04.023"},{"key":"ref102","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjz119"},{"key":"ref103","doi-asserted-by":"publisher","DOI":"10.1111\/apt.15706"},{"key":"ref104","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2020.07.012"},{"key":"ref105","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2020.06.071"},{"key":"ref106","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.15401"},{"key":"ref107","doi-asserted-by":"publisher","DOI":"10.1111\/apt.15784"},{"key":"ref108","doi-asserted-by":"publisher","DOI":"10.1177\/1756284820959245"},{"key":"ref109","first-page":"222","volume-title":"Effectiveness and safety of ustekinumab intensification at 90 mg every four weeks in Crohn\u2019s disease: a multicenter study","author":"Fumery","year":"2021"},{"key":"ref110","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2020.02.035"},{"key":"ref111","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.22954"},{"key":"ref112","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2013.01.014"},{"key":"ref113","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12313"},{"key":"ref114","doi-asserted-by":"publisher","DOI":"10.1097\/dcr.0000000000000099"},{"key":"ref115","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijsu.2013.12.015"},{"key":"ref116","doi-asserted-by":"publisher","DOI":"10.4240\/wjgs.v8.i3.274"},{"key":"ref117","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izy246"},{"key":"ref118","doi-asserted-by":"publisher","DOI":"10.1007\/s00384-019-03481-1"}],"container-title":["Intestinal Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.irjournal.org\/upload\/pdf\/ir-2022-00029.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.irjournal.org\/journal\/view.php?doi=10.5217\/ir.2022.00029","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.irjournal.org\/upload\/pdf\/ir-2022-00029.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T04:33:39Z","timestamp":1675830819000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.irjournal.org\/journal\/view.php?doi=10.5217\/ir.2022.00029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,31]]},"references-count":118,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"URL":"https:\/\/doi.org\/10.5217\/ir.2022.00029","relation":{},"ISSN":["1598-9100","2288-1956"],"issn-type":[{"value":"1598-9100","type":"print"},{"value":"2288-1956","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,31]]},"assertion":[{"value":"2022-02-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-04-18","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-10-18","order":2,"name":"published","label":"Published online","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-01-31","order":3,"name":"published","label":"Print publication","group":{"name":"publication_history","label":"Publication History"}}]}}